HFG_HOXA13-II

Gene
HOXA13
Disease
HFG-II
Inheritance
AD
Classification
Limited
Total Score
5.5
Publications Reviewed
2
Publication Span
1.63 years
Last Updated
08/18/2025
Curator(s)
Macayla Weiner, Laurel Hiatt

Description

Autosomal dominant hand-foot-genital syndrome type II (HFG-II) is supported by a heterozygous 18 bp in-frame duplication in the second HOXA13 polyalanine tract, adding six alanines. The locus-specific human evidence comes from a six-generation family with 27 affected individuals, atypical HFGS with mild limb findings and high hypospadias penetrance, significant linkage to chromosome 7p (maximum LOD 6.70 at D7S503), segregation of the HOXA13-II duplication in available affected relatives, and absence of the duplication from 100 Swedish controls.

Genetic evidence

Total: 3

Singular EvidenceProbandsPMID:126769221.5One six-generation family with 27 affected individuals and atypical HFGS carried a heterozygous 18 bp duplication in the second HOXA13 polyalanine tract (+6 alanines); the variant was absent from 100 Swedish controls.
Collective EvidenceSegregationPMID:126769221.5Genome-wide linkage mapped the trait to chromosome 7p with maximum LOD 6.70 at θ=0 for D7S503; the HOXA13-II duplication was observed in all available affected family members, with one apparently unaffected carrier noted.
2 rows

Experimental evidence

Total: 2.5

FunctionRegulatory impactPMID:15385446 PMID:126769220.5Gene-level support for HOXA13 polyalanine expansion mechanisms, including reduced protein abundance/degradation and possible dominant-negative effects
ModelsNon-human model organismPMID:153854462Gene-level, not HFG-II-specific: engineered Hoxa13 tract-III polyalanine-expansion mice (Hoxa13Ala28) showed limb phenotypes indistinguishable from Hoxa13 null mice and no homozygote survival to birth, supporting loss of function for HOXA13 polyalanine expansions. This evidence is not specific to tract-II, but supports the gene and the effect of polyalanine expansions in the gene.
2 rows

Note: Maximum score caps apply at evidence type, category, and supercategory levels, so section totals may be lower than the raw sum of row scores.